MEDIORG — Medicamen Organics Cashflow Statement
0.000.00%
- IN₹351.59m
- IN₹460.17m
- IN₹252.72m
Annual cashflow statement for Medicamen Organics, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | PROSPECTUS |
Standards: | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final |
Net Income/Starting Line | 2.47 | 0.783 | 12.5 | 33.9 |
Depreciation | ||||
Deferred Taxes | ||||
Non-Cash Items | 4.31 | 4.07 | 5.46 | 7.83 |
Unusual Items | ||||
Other Non-Cash Items | ||||
Changes in Working Capital | -27.5 | -14.3 | -32.2 | -85.8 |
Change in Accounts Receivable | ||||
Change in Inventories | ||||
Change in Other Assets | ||||
Change in Accounts Payable | ||||
Change in Other Liabilities | ||||
Other Operating Cash Flow | ||||
Cash from Operating Activities | -12.4 | -0.949 | -6.05 | -36.9 |
Capital Expenditures | — | -6.16 | -2.89 | -3.46 |
Purchase of Fixed Assets | ||||
Other Investing Cash Flow Items | 0.478 | 0.217 | 0.098 | 0.134 |
Sale of Fixed Assets | ||||
Other Investing Cash Flow | ||||
Cash from Investing Activities | 0.478 | -5.95 | -2.79 | -3.33 |
Financing Cash Flow Items | -4.43 | -4.28 | -5.55 | 5.53 |
Other Financing Cash Flow | ||||
Net Issuance / Retirement of Stock | ||||
Net Issuance / Retirement of Debt | ||||
Cash from Financing Activities | 12.9 | 2.33 | 9.99 | 40.1 |
Beginning Cash Balance | ||||
Ending Cash Balance | ||||
Net Change in Cash | 0.956 | -4.56 | 1.14 | -0.074 |